Gregory Russotti - Jul 26, 2024 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Signature
/s/ Douglas Carr, Attorney-in-Fact
Stock symbol
IPSC
Transactions as of
Jul 26, 2024
Transactions value $
-$1,465
Form type
4
Date filed
7/31/2024, 09:08 AM
Previous filing
Jul 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IPSC Common Stock Sale -$1.47K -586 -0.21% $2.50 275K Jul 26, 2024 Direct F1
holding IPSC Common Stock 92.8K Jul 26, 2024 By Gregory Russotti 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 9, 2024.

Remarks:

Title: Chief Technology and Manufacturing Officer